{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:57:00Z","timestamp":1781535420346,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.semnephrol.2008.03.009","type":"journal-article","created":{"date-parts":[[2008,6,9]],"date-time":"2008-06-09T18:46:05Z","timestamp":1213037165000},"page":"289-296","source":"Crossref","is-referenced-by-count":71,"title":["Vasopressin and Aquaporin 2 in Clinical Disorders of Water Homeostasis"],"prefix":"10.1016","volume":"28","author":[{"given":"Robert W.","family":"Schrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2008.03.009_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/357333a0","article-title":"Molecular cloning of the receptor for human antidiuretic hormone","volume":"357","author":"Birnbaumer","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-144-3-200602070-00007","article-title":"Nephrogenic diabetes insipidus","volume":"144","author":"Sands","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.1981.tb15464.x","article-title":"ADH action: evidence for a membrane shuttle mechanism","volume":"372","author":"Wade","year":"1981","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib4","doi-asserted-by":"crossref","first-page":"F463","DOI":"10.1152\/ajprenal.1993.265.4.F463","article-title":"Aquaporin CHIP the archetypal molecular water channel","volume":"265","author":"Agre","year":"1993","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/361549a0","article-title":"Cloning and expression of apical membrane water channel of rat kidney collecting tubule","volume":"361","author":"Fushimi","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physrev.00024.2001","article-title":"Aquaporins in the kidney: from molecules to medicine","volume":"82","author":"Nielsen","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib7","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1681\/ASN.2006020135","article-title":"Lithium, cyclic AMP signaling, A-kinase anchoring proteins, and aquaporin-2","volume":"17","author":"Bichet","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib8","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.1073\/pnas.91.19.8984","article-title":"Regulation of collecting duct water channel expression by vasopressin in Brattleboro rats","volume":"91","author":"DiGiovanni","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib9","doi-asserted-by":"crossref","first-page":"F723","DOI":"10.1152\/ajprenal.1994.266.5.F723","article-title":"Long-term regulation of collecting duct water permeability: freeze-fracture analysis of isolated perfused tubules","volume":"166","author":"Wade","year":"1994","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1476-5381.1992.tb09058.x","article-title":"Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist","volume":"105","author":"Yamamura","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib11","first-page":"304","article-title":"The sea within us: disorders of body water homeostasis","volume":"8","author":"Schrier","year":"2007","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/gfi082","article-title":"Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management","volume":"21","author":"Hoorn","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib13","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1681\/ASN.2006030240","article-title":"Body water homeostasis: clinical disorders of urinary dilution and concentration","volume":"17","author":"Schrier","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.73.2.257","article-title":"Prognostic importance of serum concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure","volume":"73","author":"Lee","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198107303050506","article-title":"Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure","volume":"305","author":"Szatalowicz","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib17","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1172\/JCI119312","article-title":"Upregulation of aquaporin-2 water channel expression in chronic heart failure","volume":"99","author":"Xu","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib18","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1073\/pnas.94.10.5450","article-title":"Congestive heart failure in rats in associated with increased expression and targeting of aquaporin-2 water channel in collecting duct","volume":"94","author":"Nielsen","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib19","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jacc.2005.11.071","article-title":"Aquaretic effect of lixivaptan, an oral non-peptide, selective V2 receptor vasopressin antagonist, in the New York Heart Association functional class II and III chronic heart failure patients","volume":"47","author":"Abraham","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib21","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib22","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1210\/jc.82.6.1823","article-title":"Urinary excretion of aquaporin-2 in the diagnosis of central diabetes insipidus","volume":"82","author":"Saito","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib23","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1681\/ASN.V10102165","article-title":"Selective V2 receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure","volume":"10","author":"Martin","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib24","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-113-2-155","article-title":"Body fluid volume regulation in health and disease: a unifying hypothesis","volume":"113","author":"Schrier","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib28","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1681\/ASN.2006111302","article-title":"Decreased effective blood volume in edematous disorders: what does this mean?","volume":"18","author":"Schrier","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-96-4-413","article-title":"Role of vasopressin in abnormal water excretion in cirrhotic patients","volume":"96","author":"Bichet","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0009-9236(98)90107-2","article-title":"Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis","volume":"63","author":"Inoue","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib32","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/gut.52.8.1194","article-title":"Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis","volume":"52","author":"Ivarsen","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib33","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","article-title":"Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial","volume":"124","author":"Gerbes","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib34","series-title":"Diseases of the kidney and urinary tract","first-page":"1326","article-title":"Hypertension and pregnancy","author":"Briner","year":"2007"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib35","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1046\/j.1523-1755.1998.00217.x","article-title":"Temporal relationships between hormonal and hemodynamic changes in early human pregnancy","volume":"54","author":"Chapman","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib36","first-page":"632","article-title":"Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia state","volume":"77","author":"Schrier","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib37","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1172\/JCI649","article-title":"Upregulation of aquaporin 2 water channel expression in pregnant rats","volume":"101","author":"Ohara","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"33","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib39","doi-asserted-by":"crossref","first-page":"F592","DOI":"10.1152\/ajprenal.2001.280.4.F592","article-title":"Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy","volume":"280","author":"Cadnapaphornchai","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib40","first-page":"699","article-title":"Water retention due to oxytocin","volume":"23","author":"Potter","year":"1964","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib41","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1007\/BF01950026","article-title":"Antidiuretic effects of oxytocin in the Brattleboro rat","volume":"41","author":"Lyness","year":"1985","journal-title":"Experientia"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2007010029","article-title":"Effect of oxytocin on water channel expression and trafficking in Brattleboro rats: role of V2 receptor","volume":"19","author":"Li","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0002-9343(78)90581-8","article-title":"The role of vasopressin in the impaired water excretion of myxedema","volume":"64","author":"Skowsky","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib44","doi-asserted-by":"crossref","first-page":"F672","DOI":"10.1152\/ajprenal.00384.2004","article-title":"Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism","volume":"289","author":"Chen","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib45","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1681\/ASN.2004110944","article-title":"Molecular mechanisms of impaired urinary concentrating ability in glucocorticoid-deficient rats","volume":"16","author":"Chen","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0026-0495(72)90052-2","article-title":"Primary polydipsia in thyrotoxicosis","volume":"21","author":"Evered","year":"1972","journal-title":"Metabolism"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib47","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/sj.ki.5002475","article-title":"Polyuria of thyrotoxicosis: Downregulation of aquaporin water channels and increased solute excretion","volume":"72","author":"Wang","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib48","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM197111252852205","article-title":"Tubular reabsorption of sodium ion: influence of factors other than aldosterone and glomerular filtration rate 1","volume":"285","author":"Schrier","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib49","doi-asserted-by":"crossref","first-page":"F952","DOI":"10.1152\/ajprenal.00173.2006","article-title":"Urea transporter UT-A1 and aquaporin-2 proteins decrease in response to angiotensin II or norepinephrine-induced acute hypertension","volume":"291","author":"Klein","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib50","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ki.1982.216","article-title":"Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats","volume":"22","author":"Ishikawa","year":"1982","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib51","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1172\/JCI106965","article-title":"Importance of sodium intake and mineralocorticoid hormone in the impaired water excretion in adrenal insufficiency","volume":"57","author":"Ufferman","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0006-291X(02)02634-7","article-title":"Effect of mineralocorticoid deficiency on ion and urea transporters and aquaporin water channels in the rat","volume":"299","author":"Ohara","year":"2002","journal-title":"Biochem Biophy Res Commun"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib53","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1681\/ASN.2004110944","article-title":"Molecular mechanisms of impaired urinary concentrating ability in glucocorticoid-deficient rats","volume":"16","author":"Chen","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib54","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1172\/JCI106633","article-title":"Role of antidiuretic hormone in the abnormal water diuresis of anterior hypopituitarism in man","volume":"50","author":"Agus","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib55","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1006\/bbrc.2001.6114","article-title":"Role of glucocorticoid hormones in arginine vasopressin gene regulation","volume":"289","author":"Kim","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2008.03.009_bib56","doi-asserted-by":"crossref","first-page":"F1135","DOI":"10.1152\/ajprenal.00356.2005","article-title":"Molecular analysis of impaired urinary diluting capacity in glucocorticoid deficiency","volume":"290","author":"Wang","year":"2006","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929508000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929508000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:30:03Z","timestamp":1631406603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929508000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0270929508000521"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2008.03.009","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}